Averin Capital Acquisition Corp. Units
ACAAU
NASDAQ Global Market10.15
USD
- -
- -
Averin Capital Acquisition Corp. Units
ACAAU
(NASDAQ Global Market)
Recent
price
10.15
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Averin Capital Acquisition Corp. is a blank-check company established to facilitate a merger, acquisition, reorganization, or other business combination with one or more enterprises, with a focus on technology and healthcare sectors; it aims to pursue opportunities across industries while concentrating on targets that can benefit from operational expertise and strategic capital. Founded in 2026 and headquartered in New York, the company operates as a SPAC vehicle designed to identify and consummate a qualifying business combination, leveraging a diversified management team to evaluate, structure, and execute a merger or acquisition transaction. Main products and services: initial public offering and listed SPAC vehicle units; management and oversight of the search and execution of a business combination; strategic advisory and corporate governance services during pursuit of a target merger or acquisition; post-transaction integration planning and oversight; potential ancillary financing arrangements orPIPE-type considerations as part of the business combination process. The company’s primary product is the issuance of units in its IPO, each unit comprising one Class A ordinary share and a fractional warrant, with subsequent warrants exercisable to acquire additional ordinary shares; it also provides ongoing shareholder communications, governance, and equity structuring services in relation to a completed transaction. Latest major company changes: completed the initial public offering and began trading on Nasdaq under the ticker symbol ACAAU; announces board appointments and committee structures to guide the SPAC’s governance; closes and updates on the status of the IPO, including any over-allotment activity or partial exercise of options; reports on strategic partnerships or alliances related to potential target sectors; communicates material changes in leadership or capital structure as transactions progress toward a business combination; outlines any significant operational shifts or strategic pivots in the pursuit of a technology- or healthcare-focused target. Additional context: operates as a technology- and healthcare-oriented SPAC with a structure designed to identify, evaluate, and consummate a merger, acquisition, or other business combination; targets may include software, mid- to late-stage digital health, medical devices, biopharma services, or health-tech platforms; customer base comprises institutional investors, retail shareholders, and potential target companies seeking a strategic merger partner; geography reflects a U.S.-centric operation with a focus on national deal opportunities, while regulatory and listing requirements anchor its reporting and governance standards; no disclosed subsidiaries beyond the SPAC structure; no parent company besides Averin Capital Acquisition Corp. as the standalone entity. Founding year indicates contemporaneous IPO activity in 2026, with headquarters in New York City, New York.
Company News
Averin Capital Acquisition Corp. (NASDAQ:ACAAU) Short Interest Up 2,039,640.0% in July
Averin Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 10, 2026
Averin Capital Acquisition Corp. Announces Closing of Partial Exercise of IPO Over-Allotment Option
U.S. IPO Weekly Recap: IPO Market Stays Fairly Quiet During The Short Holiday Week
Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public Offering
Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering